ProCE Banner Series

IMFINZI (durvalumab) + Gem/Cis: The First FDA Approved First-Line Treatment for Locally Advanced or Metastatic Biliary Tract Cancers

Explore a First-Line Treatment for Locally Advanced or Metastatic Biliary Tract Cancers

Key Takeaways:

  • Diagnosis and management of biliary tract cancers, TOPAZ-1 trial results, and important safety information.

All Events

IMFINZI (durvalumab) + Gem/Cis: The First FDA Approved First-Line Treatment for Locally Advanced or Metastatic Biliary Tract Cancers

Past Events

October

30

2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Sofya Pintova, MD

Assistant Professor
Ichan School of Medicine at Mount Sinai
New York, New York